Clinical Trial Update: Use of Aromatherapy to Reduce Symptom Burden [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluated aromatherapy to reduce symptom burden in patients with anxiety and chemotherapy-induced nausea and vomiting; results have been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Chemotherapy-induced Nausea and Vomiting

Snippet

Sponsor: Indiana University | Conditions: Anxiety, Chemotherapy-induced Nausea and Vomiting | Phase 2 | Status: COMPLETED | Results posted: 2024-05-16